Skip to main content
Tech.euFundingExplorerBeta

BioSimulytics

BioSimulytics develops AI-powered software for drug researchers.

BioSimulytics has raised €600k across 1 funding round from 2 investors, most recently a Seed round in Sep 2021. Based in Dublin, Ireland; active in Software and AI. Data as of 28 Oct 2026.

Total raised
€600k
€600,000
Funding rounds
1
Investors
2
distinct backers
Active since
2021-09
latest 2021-09

Funding by year

EUR raised per year
BioSimulytics — funding by year — interactive chart.
Data table
BioSimulytics — funding by year
2021€600k

Signals

High confidence
Raise-next likelihood8
base rate 44% for Seed
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▼ Low backer re-investment

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2021-09-03Seed€600kAngel Investors,Enterprise IrelandView deal →

Investors

2
Angel InvestorsEnterprise Ireland

Related news

Similar companies

same sector or country

Global coverage: FundingData